about
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriersAlbumen Transport to Bruch's Membrane and RPE by Choriocapillaris Caveolae.Challenges in design and characterization of ligand-targeted drug delivery systems.RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.αKlotho deficiency in acute kidney injury contributes to lung damage.Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Intra- and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules.Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.Acute lung injury complicating acute kidney injury: A model of endogenous αKlotho deficiency and distant organ dysfunction.A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium.Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.Uptake of Single-Walled Carbon Nanotubes Conjugated with DNA by Microvascular Endothelial Cells
P2860
Q33606794-4012FF13-168E-40E8-B3CE-D61B55D31949Q35999784-FBDD0669-EF10-4624-96B5-ECB48D694FCCQ36346851-BA92A6D9-0E33-40BF-926C-6383B7486415Q36491844-CC5EC953-B44D-40D3-A4CE-C19D0CEDBDC9Q36775310-18D1766A-81AE-429F-9DA8-AF2454B27AC9Q37514889-A770DA20-7E70-473C-BD83-B79A3E58051EQ37771030-31CB6E47-DE6E-408D-AEA9-BAEE438FBE7EQ37804385-3A442127-C84B-4D77-9488-CFDD16DA9AE3Q38836304-6A060E4E-D403-4180-A69D-5A530BE2D82EQ39021929-440FADBC-C795-4C3F-B901-8EC404E2FE56Q39203308-565B70D0-1BB7-4484-855A-32817D001DA1Q41829569-30F1FE94-7AE6-426F-B8BA-F4C37D74EDD6Q41933986-B184411B-BC20-4FDF-94B9-0EBC640C624EQ43210433-1982D8A5-AB78-4A32-961C-C35A5DF9FE07Q58910809-E31688ED-CA90-4521-ABE3-C59B75851614
P2860
description
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2006
@uk
name
Endocytosis pathways in endothelium: how many?
@en
Endocytosis pathways in endothelium: how many?
@nl
type
label
Endocytosis pathways in endothelium: how many?
@en
Endocytosis pathways in endothelium: how many?
@nl
prefLabel
Endocytosis pathways in endothelium: how many?
@en
Endocytosis pathways in endothelium: how many?
@nl
P2860
P1476
Endocytosis pathways in endothelium: how many?
@en
P2093
Radu V. Stan
P2860
P304
P356
10.1152/AJPLUNG.00533.2005
P50
P577
2006-05-01T00:00:00Z